Search results for " pharmaceutical" in Articles / App Notes
Article
Ensuring the Quality of Biologicals
Wicks, “Ensuring the Quality of Biologicals,” Pharmaceutical Technology 39 (5) 2015.
Article
Finding Opportunities in Brazil
According to the Brazilian Pharmaceutical Trade Association (Sindusfarma), the industry does not expect 2015 to be that great overall. The sector may tend to contract with a slower job growth rate, th…
Article
New Era for Generic Drugs
…ined Susan Rosencrance, then acting deputy director for generic drug chemistry in CDER’s Office of Pharmaceutical Science (OPS), at the FDA/PQRI conference in September 2014. The risk-based review ap…
Article
DoE Provides Benefits, but Preparation Is Necessary
LaBrenz, scientific director, pharmaceutical development and manufacturing sciences with Janssen Research & Development. At the same time, DoE results depend on the selected critical parameters and th…
Article
Application of Quality by Design to Viral Safety
This approach uses the concepts laid out in the International Conference on Harmonisation of Technical Requirements of Pharmaceuticals for Human Use (ICH) guidelines, Q8 Pharmaceutical Development, Q9…
Article
Novel Vaccine Technologies Meet the Need for Pandemic and Therapeutic Solutions
The company received the 2013 Facility of the Year Award issued by the International Society for Pharmaceutical Engineering (ISPE) for its flu cell-culture technology, which it has implemented at a ne…
Article
Report: Branded Biopharms Most Exposed to Biosimilar Competition
While the erosion curve will be much less steep than it is for traditional pharmaceutical products, those companies are among those that will face sales declines, Moody's reports.
But upside oppor…
Article
Determining Criticality, Part Two: DoE and Data-Driven Criticality
Prior to QbD, pharmaceutical development did not require the establishment of functional relationships between CPPs and CQAs. Consequently, process characterization experiments were primarily univaria…
Article
The Lifecycle Change of Process Validation and Analytical Testing
If adopted correctly, this guideline is good news for the regulator, the pharmaceutical manufacturer, and the patient because we will see more robust, reliable, and better value products brought to ma…
Article
The Future of Biopharma
In response, most large pharmaceutical companies are now devoting increasing development efforts on biopharmaceuticals rather than small molecule drugs. Some are now spending 40% or more of their R&D …